The gastrointestinal microbiota as a site for the biotransformation of drugs.
about
Use of Metatranscriptomics in Microbiome ResearchXenobiotics: Interaction with the Intestinal MicrofloraMicrobiology and ecology are vitally important to premedical curriculaDo interactions between gut ecology and environmental chemicals contribute to obesity and diabetes?Molecular Insights into Microbial -Glucuronidase Inhibition to Abrogate CPT-11 ToxicityThe Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for StrokeThe Impact of the Gut Microbiota on Drug Metabolism and Clinical OutcomeIn vivo and in vitro metabolites from the main diester and monoester diterpenoid alkaloids in a traditional chinese herb, the aconitum speciesDeveloping a metagenomic view of xenobiotic metabolismComparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound KDrug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?Improving the oral bioavailability of beneficial polyphenols through designed synergies.Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics.Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics.The gut microbiota: a major player in the toxicity of environmental pollutants?The intestinal metabolome: an intersection between microbiota and host.Model-based dietary optimization for late-stage, levodopa-treated, Parkinson's disease patients.Potential of an in vitro toolbox combined with exposure data as a first step for the risk assessment of dietary chemical contaminants.Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils.Data mining the human gut microbiota for therapeutic targets.Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.Effect of a soluble prebiotic fiber, NUTRIOSE, on the absorption of ginsenoside Rd in rats orally administered ginseng.Microbial determinants of biochemical individuality and their impact on toxicology and pharmacology.The microbiota, chemical symbiosis, and human disease.Mapping the inner workings of the microbiome: genomic- and metagenomic-based study of metabolism and metabolic interactions in the human microbiome.The human microbiome is a source of therapeutic drug targets.Role of metabolism by intestinal microbiota in pharmacokinetics of oral baicalin.Dysbiotic events in gut microbiota: impact on human healthCometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity.Gut microbiome-host interactions in health and disease.The effect of gut microbiota on drug metabolism.Understanding and modulating mammalian-microbial communication for improved human health.The mind-body-microbial continuumModulation of gut microbiota in the management of metabolic disorders: the prospects and challengesMicrobes, microbiota, and colon cancer.Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology?Bioequivalence of oral products and the biopharmaceutics classification system: science, regulation, and public policy.Systems biology of host-microbe metabolomics.Biotransformation and metabolic profile of caudatin-2,6-dideoxy-3-O-methy-β-d-cymaropyranoside with human intestinal microflora by liquid chromatography quadrupole time-of-flight mass spectrometry.Application of a hierarchical enzyme classification method reveals the role of gut microbiome in human metabolism.
P2860
Q26749065-CB6CCC57-3A56-4B7B-9997-F4FAF6803A85Q26795702-E697172C-ECF3-45DA-A2FF-81BB0BD5EE3AQ26801329-8B49BC1A-217F-4543-9066-5DB6F6A86110Q27010006-2B6AA744-4FB1-45BE-BF6A-843DFCA1D5F9Q27678202-98D1B0F6-BD34-4492-97F9-7A5B6E5416B3Q28069455-34A44AE8-7F87-460F-89D5-3B9C0FCFE8E2Q28071938-D294AE74-46FB-41DC-B516-77814C22B6B6Q28080742-78E8B2A0-8DE6-4471-A0FF-B3F3B465E2C8Q28273307-978E409B-AB03-476B-A040-A57582C6B988Q28487235-046712B2-462E-4BF1-95C1-82F7820EA945Q28607457-2E56C887-1E66-4523-B248-7FD8F1976B23Q33646033-DDD2F2CE-7A38-4281-B4E7-50D97B462284Q33779249-075C3ED7-EA5C-44D4-B7B9-B60AAF4DC14EQ33860494-5C131F4E-9889-4853-AACB-6FF718DA0993Q33914916-BF7A260A-CA79-4E3D-9EDE-FDC125493F76Q33915560-220BBFFB-500F-4301-B55B-B9A06DE31058Q33917819-483EA372-8D32-4F6B-81A2-38EE011EE8D8Q33962386-8A891D2F-2EE2-40F3-8485-04D2B8752170Q34063005-17CBA58E-F40D-4CBF-9FE8-1EE6475317C0Q34207728-F5F882D1-0A0B-42BB-B473-7E36D173B015Q34311685-F9D5B0C6-A521-4F69-9575-38C635590449Q34424688-89FDED67-CF92-4DEA-AB73-B7CE30FF71EDQ34615534-EADB6614-6733-4B4A-8CBC-9C4060E2A838Q34616219-3F0F33A2-BD78-4CE0-9DE4-7A423BE59C7EQ34616367-99B0A226-366A-48B8-89B2-23328F7FA98BQ34726528-E9551B9A-E753-453F-8D44-9703B21F8A83Q34774595-B78CFEB9-1D55-4853-BB52-608C0FD9DC06Q34775051-251AD9DF-4CDB-42EC-ADCC-E8F5264CF149Q34915414-49E417CD-3BE2-4E16-A09F-4CDA3E9DE23AQ34971430-0C7E449B-6386-486E-9D39-FDBA965D061AQ34986604-68F7B5CA-B77B-4F98-8247-8907B847D5E8Q35026463-12FDC5D5-E607-4ED7-93B3-AC3FA9ED7235Q35114569-358000AF-57A3-4CE0-9ACE-A1BD8EC51531Q35114851-45A7E83B-6FE8-4D8E-BD70-A154FC86AAABQ35120938-3A87F6D7-0DF6-49C5-B393-612204BA7E70Q35492374-19A3E8A3-647D-4238-8A7A-14516C0B156EQ35586444-E65E10A9-01F3-47E4-8836-3C67BA17F769Q35619563-9A3BDB3E-D036-451A-8760-CBC6B6347C2EQ35644109-A87FC125-9C53-4FB0-858A-49C298931144Q35671178-BFECB660-E1CF-4B45-8108-2798E4956FDB
P2860
The gastrointestinal microbiota as a site for the biotransformation of drugs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The gastrointestinal microbiota as a site for the biotransformation of drugs.
@en
The gastrointestinal microbiota as a site for the biotransformation of drugs.
@nl
type
label
The gastrointestinal microbiota as a site for the biotransformation of drugs.
@en
The gastrointestinal microbiota as a site for the biotransformation of drugs.
@nl
prefLabel
The gastrointestinal microbiota as a site for the biotransformation of drugs.
@en
The gastrointestinal microbiota as a site for the biotransformation of drugs.
@nl
P2093
P1476
The gastrointestinal microbiota as a site for the biotransformation of drugs.
@en
P2093
Abdul W Basit
Anders Carlsson
Bertil Abrahamsson
Ronnie Paterson
Tiago Sousa
Vanessa Moore
P356
10.1016/J.IJPHARM.2008.07.009
P407
P577
2008-07-16T00:00:00Z